Over the years, we know you've come to expect the best American Society of Clinical Oncology (ASCO) coverage from us. In anticipation of this year's conference, held June 1-5, 2018 in Chicago, we wanted to provide you a summary of the various ways Biomedtracker and Datamonitor Healthcare will keep you up-to-date on the biggest oncology event of the year.

This Week - ASCO Planner
Stay prepared and grab a copy of our useful ASCO Planner, available later this week. The planner is designed to be an easy-to-view presentation of the maze of concurrent sessions during the meeting.

May 16 - Pre-ASCO Abstract Release Night Report
Our real-time coverage kicks off Wednesday, May 16th, with our annual Abstract Release Night primer. You can expect our coverage of the major, potentially market-moving abstracts released at 5pm EST and our 'Companies to Watch' list to be in your inbox when you wake up Thursday morning. For last year's coverage, see here.

May 23 - Pre-Meeting ASCO Essentials Webinar
As an accompaniment to the Pre-ASCO report, join a panel of Informa Pharma Intelligence analysts as they hold a roundtable discussion of the abstracts to help you navigate the flood of data in the abstract release. Register here!

June 3 - ASCO Weekend Update
Along with many events added to the Biomedtracker database over the weekend, our analysts will be attending the ASCO conference and providing their boots-on-the-ground commentary both in our Biomedtracker events, and in a 'Weekend Update', published before you start your day Monday morning. For an example of past Weekend Reports, see here.

Shortly following the conference - Post-Meeting Podcast
A panel of Informa analysts will discuss the major developments of the conference and key insights via a podcast recorded directly after the meeting concludes. Join our analysts as they debrief following the conclusion of the conference with their rapid takeaways and key highlights.

Shortly following the conference - Post-ASCO Report
Once our analysts return from the conference and all of the Informa Pharma coverage is completed, the team will publish a comprehensive wrap-up of the conference and provide insights on material updates in various oncology indications. For an example of last year's post-report, see here.